Modification to the Emit II Plus Cocaine Metabolite Assay

FDA 510(k) K011162 · Syva Co., Dade Behring, Inc.

Substantially Equivalent

510(k) numberK011162

Submission

Device name
Modification to the Emit II Plus Cocaine Metabolite Assay
Applicant
Syva Co., Dade Behring, Inc.
San Jose, CA, US
Received
April 16, 2001
Decision date
May 2, 2001
Decision
Substantially Equivalent (SESE)
Type
Special 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
DIO – Enzyme Immunoassay, Cocaine And Cocaine Metabolites
Device class
Class II (moderate risk)
Regulation
21 CFR 862.3250
Specialty
Clinical Toxicology

Other 510(k)s with product code DIO

510(k)DeviceApplicantDecision
K213211Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Enzyme Immunoassay (COCM)…DIO · Traditional Carolina Liquid Chemistries Corp.01/27/2022SE
K211973DRI Cocaine Metabolite AssayDIO · Traditional Microgenics Corporation09/24/2021SE
K191638Pointe Scientific Cocaine Metabolite Enzyme ImmunoassayDIO · Traditional Medtest DX03/12/2020SE
K181499DRI Cocaine Metabolite AssayDIO · Traditional Microgenics Corporation07/06/2018SE
K170293Emit II Plus Cocaine Metabolite AssayDIO · Traditional Siemens Healthcare Diagnostics, Inc.10/25/2017SE
K163570Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Test System (COCM)DIO · Traditional Carolina Liquid Chemistries Corporation08/15/2017SE
K162395MP DOA-10 Panel Test Cup, MP DOA-11 Panel Test CupDIO · Special Mp Biomedicals, LLC06/02/2017SE
K152232Quest Diagnostics HairCheck-DT (Cocaine)DIO · Traditional Quest Diagnostics Incorporated11/18/2016SE
K161214Wondfo Amphetamine Urine Test AMP 500 (Cup, Dipcard), Wondfo Cocaine Urine Test COC…DIO · Traditional Guangzhou Wondfo Biotech Co., Ltd.06/27/2016SE
K153646SAFECARE Urine Test Amphetamine, SAFECARE Urine Test Cocaine, SAFECARE Urine Test…DIO · Traditional Safecare Biotech (Hangzhou) Co., Ltd.03/18/2016SE

More from Safecare Biotech (Hangzhou) Co., Ltd.

510(k)DeviceDecision
K011920Emit 2000 Digoxin Assay, Model OSR4H229KXT · Special 07/02/2001SE
K011620Emit 2000 N-Acetylprocainamide Assay, Model OSR4N229LAN · Special 06/18/2001SE
K011605Emit 2000 Quinidine Assay, Model OSR4Q229LBZ · Special 06/12/2001SE
K011300Emit II Plus Cannabinoid Assay, Model OSR9N229LDJ · Special 05/17/2001SE
K011306Emit II Plus Benzodiazepine Assay, Model 0SR9F229JXM · Special 05/16/2001SE
K011289Emit II Plus Opiate Assay, Model OSR9B229DJG · Special 05/15/2001SE
K011161Modification to the Emit II Plus Phencyclidine Assay, Model OSR9J229LCM · Special 05/15/2001SE
K011166Modification to Emit 2000 Theophylline Assay, Model Osr 4P229KLS · Special 05/10/2001SE
K011164Modification to the Emit II Plus Methaqualone Assay, Model OSR9Q229KXS · Special 05/10/2001SE
K011163Modification to the Emit II Plus Propoxyphene Assay, Model OSR9G229JXN · Special 05/10/2001SE

Questions and answers

When was Modification to the Emit II Plus Cocaine Metabolite Assay cleared by the FDA?

Modification to the Emit II Plus Cocaine Metabolite Assay (K011162) received a 510(k) decision of Substantially Equivalent on May 2, 2001, 16 days after the submission was received.

What is the product code of K011162?

The FDA product code is DIO – Enzyme Immunoassay, Cocaine And Cocaine Metabolites, a Class II (moderate risk) device regulated under 21 CFR 862.3250.